Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase
- 1 January 2016
- journal article
- Published by Elsevier in Vascular Pharmacology
- Vol. 76, 62-71
Abstract
No abstract availableKeywords
Funding Information
- Bristol Myers Squibb/Astra Zeneca (539999-2013)
This publication has 38 references indexed in Scilit:
- Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safetyExpert Opinion on Pharmacotherapy, 2013
- The Assessment of Endothelial FunctionCirculation, 2012
- Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillariesBiological Chemistry, 2011
- Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 productsBritish Journal of Pharmacology, 2011
- Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signallingCardiovascular Research, 2009
- Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood PressureArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Persistent Remodeling of Resistance Arteries in Type 2 Diabetic Patients on Antihypertensive TreatmentHypertension, 2004
- Prognostic Significance of Small-Artery Structure in HypertensionCirculation, 2003
- The Role of Dipeptidyl Peptidase IV (DP IV) Enzymatic Activity in T Cell Activation and AutoimmunityBiological Chemistry, 2002
- Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitusJournal Of Hypertension, 2001